Medical News

RSS

Second-quarter results enable Meridian achieve a 3-year compound annual growth rate of 72.8 percent

Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.

24 Aug 2009

Capital Earnings & Research to launch prostate cancer awareness campaign

What did all the following businessmen have in common?

24 Aug 2009

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease). The company expects to begin Phase I clinical studies in 2010.

24 Aug 2009

Economic professors at Baylor suggest that insurance reform must expand coverage to the uninsured 37 million Americans

Two professors at Baylor University's Hankamer School of Business lay out a universal health care plan in their new book Health Care for Us All: Getting More for Our Investment, published by Cambridge University Press, that does not create a government entitlement program or threaten in any way the insurance coverage or health care of Americans who currently have coverage.

24 Aug 2009

Merck to hold conference call on its third-quarter 2009 results with institutional investors and analysts

Merck & Co., Inc. will hold its third-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 9:00 a.m. EDT on Thursday, Oct. 22. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter.

24 Aug 2009

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

CSL Biotherapies has announced the initiation of the company’s first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL’s candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.

24 Aug 2009

Authentidate to provide web-based healthcare documentation process to LifeCare Solutions

Authentidate Holding Corp. (Nasdaq: ADAT), a worldwide provider of secure Health Information Exchange and workflow management services, today announced that LifeCare Solutions, Inc., a leading Western U.S. provider of home healthcare services and medical equipment, selected Authentidate's Inscrybe(TM) Healthcare web-based service to simplify completion of healthcare documentation with physicians.

24 Aug 2009

Osteologix announces receipt of Decision to Grant a Patent from JPO for NB S101 osteoporosis drug candidate

Osteologix, Inc. (OTCBB:OLGX) today announced that the Japan Patent Office (JPO) has issued a Decision to Grant a Patent for Application Number 2006-504379: "Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts". The patent claims cover the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate.

24 Aug 2009

Foamix's novel foam technology awarded US patent

Foamix Ltd., a leading developer of topical foams for dermatology and gynecology, announced today that it has been awarded US Patent #7575739 pertaining to its foam technology. The patent covers unique foam compositions, suitable for the treatment of heat and chemical burns, wounds, bacterial, fungal and viral infections.

24 Aug 2009

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has granted their petition for rehearing en banc and has vacated its April 2009 decision in the appeal that Eli Lilly and Co. filed in 2008. All twelve judges of the Federal Circuit will now rehear and reassess the merits of Lilly’s appeal.

24 Aug 2009

Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Located in Guangzhou, Sun Yat-Sen University Cancer Center is one of China's renowned cancer research institutions, prominent in pre-clinical and clinical oncology research. The Sun Yat-Sen University Cancer Center was established to research anti-cancer treatments with a specific focus on developing major innovative drugs.

24 Aug 2009

Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.

24 Aug 2009

PatientKeeper's user community grows more than 60% in the last 12 months

PatientKeeper®, Inc., the leading developer of physician information systems, reported continued growth in the first half of 2009. This growth was driven by new customers including Pennsylvania’s Butler Health System, North Carolina’s Catawba Valley Medical Center and Michigan’s Oakwood Healthcare System and by existing customers adopting new products.

24 Aug 2009

MIT to honor Dr. Khine of Shrink Nanotechnologies as one of the top 35 global innovators

Shrink Nanotechnologies, Inc. (“Shrink”) (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) solar energy production, (ii) medical diagnostics and sensors and (iii) biotechnology research and development tools, today announced that Dr. Michelle Khine, Ph.D., the scientific founder of Shrink’s nanofabrication platform, was named by MIT Technology Review as one of the top 35 global innovators under the age of 35.

24 Aug 2009

Nutra-Life develops new delivery system for supplements

Nutra-Life Inc., a Boise-based company has launched a new enhanced beverage company that features five all-natural supplement products that are delivered through its revolutionary Nutra-Life Inc. cap while drinking water from a bottle.

24 Aug 2009

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

Curemark Founder and CEO Dr. Joan Fallon delivered the Industry Keynote address at the Third International Epigenomics, Sequencing 2009 Conference at Harvard Medical School on July 14th

24 Aug 2009

XSpray Microparticles launches GMP production facility in Sweden

Karolinska Development (publ), managing one of the largest portfolios of life science research companies in Europe, announced that XSpray Microparticles AB has launched a GMP production facility in Malmo, Sweden. In addition to offering particle development and characterization services, XSpray can now provide customers with high quality drug particles and powders for use in their clinical studies.

24 Aug 2009

Staywell Custom Communications partners with Self Care Decisions to provide online applications for health care providers

Custom health communications company StayWell Custom Communications (SCC), a division of MediMedia USA, has announced an exclusive strategic alliance with Self Care Decisions, LLC, the leading provider of decision-support care guides for consumers via the Internet and mobile applications.

24 Aug 2009

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the third quarter ended June 30, 2009.

24 Aug 2009

Study reveals that increased neurostimulation market offers growth for device industries

The device industry would do well to focus on the treatment needs of individuals suffering from nerve-related disorders as implanted technologies that deliver electrical stimulation begin to supplant drugs for treating certain nerve-related disorders.

24 Aug 2009

Medical News

Second-quarter results enable Meridian achieve a 3-year compound annual growth rate of 72.8 percent

Capital Earnings & Research to launch prostate cancer awareness campaign

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

Economic professors at Baylor suggest that insurance reform must expand coverage to the uninsured 37 million Americans

Merck to hold conference call on its third-quarter 2009 results with institutional investors and analysts

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

Authentidate to provide web-based healthcare documentation process to LifeCare Solutions

Osteologix announces receipt of Decision to Grant a Patent from JPO for NB S101 osteoporosis drug candidate

Foamix's novel foam technology awarded US patent

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs

Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data

PatientKeeper's user community grows more than 60% in the last 12 months

MIT to honor Dr. Khine of Shrink Nanotechnologies as one of the top 35 global innovators

Nutra-Life develops new delivery system for supplements

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

XSpray Microparticles launches GMP production facility in Sweden

Staywell Custom Communications partners with Self Care Decisions to provide online applications for health care providers

SQI Diagnostics continues discussions with the FDA to market it's SQiDworks Diagnostics Platform in the US

Study reveals that increased neurostimulation market offers growth for device industries

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News